152 related articles for article (PubMed ID: 16888174)
1. Molecular approximation between residue 10 of secretin and its receptor demonstrated by photoaffinity labeling.
Dong M; Miller LJ
Ann N Y Acad Sci; 2006 Jul; 1070():243-7. PubMed ID: 16888174
[TBL] [Abstract][Full Text] [Related]
2. Differential spatial approximation between secretin and its receptor residues in active and inactive conformations demonstrated by photoaffinity labeling.
Dong M; Hosohata K; Pinon DI; Muthukumaraswamy N; Miller LJ
Mol Endocrinol; 2006 Jul; 20(7):1688-98. PubMed ID: 16513792
[TBL] [Abstract][Full Text] [Related]
3. Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.
Dong M; Lam PC; Gao F; Hosohata K; Pinon DI; Sexton PM; Abagyan R; Miller LJ
Mol Pharmacol; 2007 Aug; 72(2):280-90. PubMed ID: 17475809
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.
Miller LJ; Dong M; Harikumar KG; Gao F
Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130
[TBL] [Abstract][Full Text] [Related]
5. Use of photoaffinity labeling to understand the molecular basis of ligand binding to the secretin receptor.
Dong M; Miller LJ
Ann N Y Acad Sci; 2006 Jul; 1070():248-64. PubMed ID: 16888175
[TBL] [Abstract][Full Text] [Related]
6. Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10.
Dong M; Pinon DI; Miller LJ
Regul Pept; 2002 Nov; 109(1-3):181-7. PubMed ID: 12409231
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling.
Dong M; Wang Y; Pinon DI; Hadac EM; Miller LJ
J Biol Chem; 1999 Jan; 274(2):903-9. PubMed ID: 9873030
[TBL] [Abstract][Full Text] [Related]
8. Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor.
Zang M; Dong M; Pinon DI; Ding XQ; Hadac EM; Li Z; Lybrand TP; Miller LJ
Mol Pharmacol; 2003 May; 63(5):993-1001. PubMed ID: 12695527
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of a specific site of covalent labeling of the human motilin receptor using a biologically active photolabile motilin analog.
Matsuura B; Dong M; Coulie B; Pinon DI; Miller LJ
J Pharmacol Exp Ther; 2005 Jun; 313(3):1101-8. PubMed ID: 15677347
[TBL] [Abstract][Full Text] [Related]
10. Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor.
Dong M; Wang Y; Hadac EM; Pinon DI; Holicky E; Miller LJ
J Biol Chem; 1999 Jul; 274(27):19161-7. PubMed ID: 10383421
[TBL] [Abstract][Full Text] [Related]
11. Spatial approximation between the amino terminus of a peptide agonist and the top of the sixth transmembrane segment of the secretin receptor.
Dong M; Li Z; Pinon DI; Lybrand TP; Miller LJ
J Biol Chem; 2004 Jan; 279(4):2894-903. PubMed ID: 14593094
[TBL] [Abstract][Full Text] [Related]
12. Insights into the structure and molecular basis of ligand docking to the G protein-coupled secretin receptor using charge-modified amino-terminal agonist probes.
Dong M; Pinon DI; Miller LJ
Mol Endocrinol; 2005 Jul; 19(7):1821-36. PubMed ID: 15731172
[TBL] [Abstract][Full Text] [Related]
13. Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors.
Dong M; Pinon DI; Asmann YW; Miller LJ
Mol Pharmacol; 2006 Jul; 70(1):206-13. PubMed ID: 16531505
[TBL] [Abstract][Full Text] [Related]
14. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
Dong M; Liu G; Pinon DI; Miller LJ
Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
[TBL] [Abstract][Full Text] [Related]
15. Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus.
Dong M; Zang M; Pinon DI; Li Z; Lybrand TP; Miller LJ
Mol Endocrinol; 2002 Nov; 16(11):2490-501. PubMed ID: 12403838
[TBL] [Abstract][Full Text] [Related]
16. Identification of two pairs of spatially approximated residues within the carboxyl terminus of secretin and its receptor.
Dong M; Asmann YW; Zang M; Pinon DI; Miller LJ
J Biol Chem; 2000 Aug; 275(34):26032-9. PubMed ID: 10859300
[TBL] [Abstract][Full Text] [Related]
17. Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor.
Dong M; Li Z; Zang M; Pinon DI; Lybrand TP; Miller LJ
J Biol Chem; 2003 Nov; 278(48):48300-12. PubMed ID: 14500709
[TBL] [Abstract][Full Text] [Related]
18. Dual contacts between peptide agonist ligands and the secretin receptor directly established by photoaffinity labeling.
Dong M; Wang Y; Miller LJ
Ann N Y Acad Sci; 2000; 921():381-6. PubMed ID: 11193860
[TBL] [Abstract][Full Text] [Related]
19. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
Ozcelebi F; Holtmann MH; Rentsch RU; Rao R; Miller LJ
Mol Pharmacol; 1995 Nov; 48(5):818-24. PubMed ID: 7476911
[TBL] [Abstract][Full Text] [Related]
20. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
Hadac EM; Ji Z; Pinon DI; Henne RM; Lybrand TP; Miller LJ
J Med Chem; 1999 Jun; 42(12):2105-11. PubMed ID: 10377216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
